These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10950669)

  • 21. [Is accepting an invitation to a conference on Hawaii unethical?].
    Andrén-Sandberg A
    Lakartidningen; 2005 Apr 4-10; 102(14):1057-8, 1060. PubMed ID: 15892476
    [No Abstract]   [Full Text] [Related]  

  • 22. Industry support of CME--are we at the tipping point?
    Steinman MA; Landefeld CS; Baron RB
    N Engl J Med; 2012 Mar; 366(12):1069-71. PubMed ID: 22435367
    [No Abstract]   [Full Text] [Related]  

  • 23. AMA forges ahead. Unveiling of educational campaign paid by drug industry triggers new criticism.
    Romano M
    Mod Healthc; 2001 Sep; 31(37):22-3. PubMed ID: 11573355
    [No Abstract]   [Full Text] [Related]  

  • 24. Profits, pressure, and perception: expensive research collides with medicine.
    Hoey J
    J Rheumatol; 2003 Aug; 30(8):1661-2. PubMed ID: 12913915
    [No Abstract]   [Full Text] [Related]  

  • 25. Research dishonesty and conflict of interest.
    Frizelle F
    N Z Med J; 2002 Dec; 115(1167):U270. PubMed ID: 12552259
    [No Abstract]   [Full Text] [Related]  

  • 26. American academy of pain medicine ethics council statement on conflicts of interest: interaction between physicians and industry in pain medicine.
    Dubois MY;
    Pain Med; 2010 Feb; 11(2):257-62. PubMed ID: 19930112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uneasy alliance--clinical investigators and the pharmaceutical industry.
    Bodenheimer T
    N Engl J Med; 2000 May; 342(20):1539-44. PubMed ID: 10816196
    [No Abstract]   [Full Text] [Related]  

  • 28. Must "no see" always mean a "no know"?
    Gamble GL
    PM R; 2009 Jan; 1(1):87-8. PubMed ID: 19627879
    [No Abstract]   [Full Text] [Related]  

  • 29. Is academic psychiatry for sale?
    Healy D; Thase ME
    Br J Psychiatry; 2003 May; 182():388-90. PubMed ID: 12724241
    [No Abstract]   [Full Text] [Related]  

  • 30. [Legal aspects of support to clinics, research and continuing education by industry].
    Räpple T
    Z Gastroenterol; 1999 Jul; Suppl 2():33-7. PubMed ID: 10472697
    [No Abstract]   [Full Text] [Related]  

  • 31. Rethinking continuing medical education.
    Pisacane A
    BMJ; 2008 Aug; 337():a973. PubMed ID: 18703654
    [No Abstract]   [Full Text] [Related]  

  • 32. [Drug industry and bribes].
    Annertz M
    Lakartidningen; 2004 Apr; 101(15-16):1436. PubMed ID: 15146680
    [No Abstract]   [Full Text] [Related]  

  • 33. Guidelines for faculty involvement in commercially supported continuing medical education. AAMC Ad Hoc Committee on Misconduct and Conflict of Interest in Research. AAMC Subcommittee on Conflict of Interest in Continuing Medical Education.
    Acad Med; 1992 Sep; 67(9):615-21. PubMed ID: 1520428
    [No Abstract]   [Full Text] [Related]  

  • 34. Rebuttal: Is CME a drug-promotion tool?: YES.
    Steinman MA; Baron RB
    Can Fam Physician; 2007 Nov; 53(11):1877, 1878-9. PubMed ID: 18000249
    [No Abstract]   [Full Text] [Related]  

  • 35. Medical professionalism--focusing on the real issues.
    Ruane TJ
    N Engl J Med; 2000 Sep; 343(10):739-40. PubMed ID: 10979775
    [No Abstract]   [Full Text] [Related]  

  • 36. Industry spending on continuing medical education in US falls further.
    Roehr B
    BMJ; 2012 Aug; 345():e5336. PubMed ID: 22872716
    [No Abstract]   [Full Text] [Related]  

  • 37. [Physicians and drug industry: attitudes and practice].
    Aasland OG; Førde R
    Tidsskr Nor Laegeforen; 2004 Oct; 124(20):2603-6. PubMed ID: 15534631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do doctors rely on pharmaceutical industry funding to attend conferences and do they perceive that this creates a bias in their drug selection? Results from a questionnaire survey.
    Rutledge P; Crookes D; McKinstry B; Maxwell SR
    Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):663-7. PubMed ID: 14762982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NerveCenter: Office of Inspector General warns NIH on lax COI oversight as many academic medical centers look inward.
    Samson K
    Ann Neurol; 2010 Mar; 67(3):A7-A10. PubMed ID: 20373337
    [No Abstract]   [Full Text] [Related]  

  • 40. Prescription for conflict. AMA accepts funding from drug firms for campaign.
    Romano M
    Mod Healthc; 2001 Jun; 31(25):14. PubMed ID: 11436381
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.